Skip to NavigationSkip to content

Pharmafile - Research and Development News

Vertex has revealed that it has secured a new approval from the European Commission for its therapy Kalydeco (ivacaftor) in the treatment of cystic...
Hydroxychloroquine as a potential coronavirus treatment continues to be a contentious issue, as a new study led by researchers at the University of...
Danish neuroscience specialist Lundbeck has announced it will be implementing a restructure of its Research & Development operations – a move...
A US clinical trial of the drug ivermectin found that it reduced the mortality rate of COVID-19 patients by 40%.
Alnylam has presented promising new Phase 3 data at the European Renal Association-European Dialysis and Transplant Association International...
AstraZeneca has shed light on the possible efficacy of its Bruton’s tyrosine kinase (BTK) inhibitor Calquence (acalabrutinib) in the treatment of...
This week has seen the development of coronavirus vaccines move forward, as the Trump administration has selected the finalists for the COVID-19...
New Phase 3 data has been released on the efficacy of Novartis’ interleukin (IL)-17A inhibitor Cosentyx (secukinumab), showing that the therapy led...
Janssen has revealed data from two Phase 3 trials for Tremfya (guselkumab), showing improvement in skin clearance and symptoms in adult patients with...
India and South Korea have moved to follow in the footsteps of the US in approving Gilead’s antiviral therapy remdesivir for emergency use in a bid...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches